Not all of the non-competitive anti-ErbB2 mAb pairs induce ErbB2 internalization.
A bispecific antibody was engineered from two non-competitive anti-ErbB2 mAbs.
This bispecific antibody shows enhanced ErbB2 internalization-inducing ability.
This bispecific antbody exhibits extremely potent antitumor activity.